Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An In Vitro Pilot Study

被引:47
作者
Di Vito, Anna [1 ]
Chiarella, E. [1 ]
Baudi, F. [1 ]
Scardamaglia, P. [1 ]
Antonelli, A. [2 ]
Giudice, D. [1 ]
Barni, T. [1 ]
Fortunato, L. [2 ]
Giudice, A. [2 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
关键词
zoledronic acid; human periodontal ligament stem cells; osteogenic differentiation; cell cultures;
D O I
10.1177/0963689720948497
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bisphosphonates (BPs) are widely used to treat several metabolic and oncological diseases affecting the skeletal system. Despite BPs' well-known therapeutic potential, they also displayed important side effects, among which is BPs-related osteonecrosis of the jaw, by targeting osteoclast activities, osteoblast, and osteocyte behavior. The aim of this study is to evaluate the biological effects of zoledronic acid (ZOL) in an in vitro model of periodontal ligament stem cells (PDLSCs) by using an experimental setting that resembles the in vivo conditions. PDLSCs were treated with different concentrations of ZOL ranging from 0.1 to 5 mu M. The effects of ZOL exposure were evaluated on cell viability via 3-[4,5-Dimethylthiaoly]-2,5-diphenyltetrazolium bromide (MTT), cell cycle analysis, apoptosis detection, and immunofluorescence. Quantitative real-time polymerase chain reaction (PCR), colorimetric detection of alkaline phosphatase activity, and Alizarin Red S staining were performed to investigate the osteogenic potential of PDLSCs exposed to ZOL. MTT analysis showed that the viability of PDLSCs exposed to ZOL concentration >= 1.5 mu M for 3 and 6 days was significantly lower (P < 0.001) than that of untreated cells. The percentage of apoptotic cells was significantly higher in PDLSCs exposed for 4 days to ZOL at 2 mu M (P < 0.01) and 5 mu M (P < 0.001) when compared to the control. Moreover, ZOL treatment (3 days) accounted for alterations in cell cycle distribution, with an increase in the proportion of cells in G0/G1 phase and a reduction in the proportion of cells in S phase. Chronic exposure (longer than 7 days) of PDLSCs to ZOL accounted for the downregulation of ALP, RUNX2, and COL1 genes at all tested concentrations, which fit well with the reduced alkaline phosphatase activity reported after 7 and 14 days of treatment. Reduced Col1 deposition in the extracellular matrix was reported after 14 days of treatment. Increased calcium deposits were observed in treated cells when compared to the control cultures. In conclusion, chronic exposure to 1 mu M ZOL induced significant reduction of osteogenic differentiation, while ZOL concentrations >= 1.5 mu M are required to impair PDLSCs viability and induce apoptosis.
引用
收藏
页数:12
相关论文
共 51 条
[1]   The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells [J].
Acil, Y. ;
Moeller, B. ;
Niehoff, P. ;
Rachko, K. ;
Gassling, V. ;
Wiltfang, J. ;
Simon, M. J. K. .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2012, 40 (08) :E229-E235
[2]   Is Zoledronate Toxic to Human Periodontal Fibroblasts? [J].
Agis, H. ;
Blei, J. ;
Watzek, G. ;
Gruber, R. .
JOURNAL OF DENTAL RESEARCH, 2010, 89 (01) :40-45
[3]   MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer [J].
Biamonte, Flavia ;
Santamaria, Gianluca ;
Sacco, Alessandro ;
Perrone, Francesca Marta ;
Di Cello, Annalisa ;
Battaglia, Anna Martina ;
Salatino, Alessandro ;
Di Vito, Anna ;
Aversa, Ilenia ;
Venturella, Roberta ;
Zullo, Fulvio ;
Costanzo, Francesco .
SCIENTIFIC REPORTS, 2019, 9 (1)
[4]   R115777 (Zarnestra®)/Zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation [J].
Caraglia, Michele ;
Marra, Monica ;
Leonetti, Carlo ;
Meo, Giuseppina ;
D'Alessandro, Anna Maria ;
Baldi, Alfonso ;
Santini, Danele ;
Tonini, Giuseppe ;
Bertieri, Raffaello ;
Zupi, Gabriella ;
Budillon, Alfredo ;
Abbruzzese, Alberto .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (02) :533-543
[5]   Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases [J].
Chen, TL ;
Berenson, J ;
Vescio, R ;
Swift, R ;
Gilchick, A ;
Goodin, S ;
LoRusso, P ;
Ma, PM ;
Ravera, C ;
Deckert, F ;
Schran, H ;
Seaman, J ;
Skerjanec, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) :1228-1236
[6]   ZNF521 Represses Osteoblastic Differentiation in Human Adipose-Derived Stem Cells [J].
Chiarella, Emanuela ;
Aloisio, Annamaria ;
Scicchitano, Stefania ;
Lucchino, Valeria ;
Montalcini, Ylenia ;
Galasso, Olimpio ;
Greco, Manfredi ;
Gasparini, Giorgio ;
Mesuraca, Maria ;
Bond, Heather M. ;
Morrone, Giovanni .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
[7]   Recent advances in understanding the mechanism of action of bisphosphonates [J].
Coxon, Fraser P. ;
Thompson, Keith ;
Rogers, Michael J. .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (03) :307-312
[8]   Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts [J].
De Colli, Marianna ;
Zara, Susi ;
di Giacomo, Viviana ;
Patruno, Antonia ;
Marconi, Guya Diletta ;
Gallorini, Marialucia ;
Zizzari, Vincenzo Luca ;
Tete, Giulia ;
Cataldi, Amelia .
CLINICAL ORAL INVESTIGATIONS, 2015, 19 (06) :1269-1277
[9]   In Vitro Long-Term Expansion and High Osteogenic Potential of Periodontal Ligament Stem Cells: More Than a Mirage [J].
Di Vito, Anna ;
Giudice, Amerigo ;
Chiarella, Emanuela ;
Malara, Natalia ;
Bennardo, Francesco ;
Fortunato, Leonzio .
CELL TRANSPLANTATION, 2019, 28 (01) :129-139
[10]   Overstimulation of Glutamate Signals Leads to Hippocampal Transcriptional Plasticity in Hamsters [J].
Di Vito, Anna ;
Mele, Maria ;
Piscioneri, Antonella ;
Morelli, Sabrina ;
De Bartolo, Loredana ;
Barni, Tullio ;
Facciolo, Rosa Maria ;
Canonaco, Marcello .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2014, 34 (04) :501-509